Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference

Core Insights - Eledon Pharmaceuticals, Inc. will present at the Guggenheim Second Annual Healthcare Innovation Conference on November 12, 2025, at 10:30 a.m. ET [1] - The company is focused on developing immune-modulating therapies for life-threatening conditions, with its lead product being tegoprubart, an anti-CD40L antibody [2] Company Overview - Eledon Pharmaceuticals is a clinical stage biotechnology company headquartered in Irvine, California [2] - The company is developing therapies targeting CD40 Ligand, which has significant therapeutic potential in various medical conditions [2] - Eledon is conducting preclinical and clinical studies in areas such as kidney allograft transplantation, xenotransplantation, and amyotrophic lateral sclerosis (ALS) [2]